Results of hematopoietic stem cell transplant in Shiraz: 15 Years' experience in southern Iran

Experimental and Clinical Transplantation

Volumn 8, Issue 1, 2010, Pages 61-65

  Ramzi, Mani ^a   Nourani, Habib ^a   Zakerinia, Maryam ^a   Dehghani, Mehdi ^a   Vojdani, Reza ^a   Haghshenas, Mansour ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

B thalassemia; Bone marrow; Leukemia

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; THYMOCYTE ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BETA THALASSEMIA; CANCER CHEMOTHERAPY; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENGRAFTMENT; FOLLOW UP; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC SYSTEM; HIGH RISK POPULATION; HUMAN; IRAN; LEUKEMIA; MAJOR CLINICAL STUDY; MYELOID LEUKEMIA; OUTCOME ASSESSMENT; PRESCHOOL CHILD; SCHOOL CHILD; THALASSEMIA; UNIVERSITY;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DRUG THERAPY; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IRAN; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77749340800     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354(17):1813-1826.
2. Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant. 2006;37(5):439-449.
3. Zakerinia M, Khojasteh HN, Ramzi M, Amirghofran Z, Tabei Z, Haghshenas M. Bone marrow transplantation for thalassemia in Shiraz. Transplant Proc. 1995;27(5):2659-2660.
4. Ramzi M, Nourani H, Zakernia M, Hamidian Jahromi AR. Hematopoietic stem cell transplantation for beta-thalassemia major: experience in south of Iran. Transplant Proc. 2004;36(8):2509-2510.
5. Gratwohl A, Baldomero H, Frauendorfer K, Niederwieser D; Joint Accreditation Committee of the International Society for Cellular Therapy ISCT; European Group for Blood and Marrow Transplantation EMBT (JACIE). Why are there regional differences in stem cell transplantation activity? An EBMT analysis. Bone Marrow Transplant. 2008;42(suppl 1):S7-S10.
6. Lucarelli G, Galimberti M, Polchi P, et al. Bonemarrow transplantation in patients with thalassemia. N Engl J Med. 1990;322(7):417-421.
7. Lucarelli G, Polchi P, Izzi T, et al. Allogeneic marrow transplantation for thalassemia. Exp Hematol. 1984;12(8):676-681.
8. Lucarelli G, Polchi P, Galimberti M, et al. Marrow transplantation for thalassaemia following busulphan and cyclophosphamide. Lancet. 1985;1(8442):1355-1357.
9. Lucarelli G, Galimberti M, Polchi P, et al. Marrow transplantation in patients with advanced thalassemia. N Engl J Med. 1987;316(17):1050-1055.
10. Lucarelli G, Weatherall DJ. For debate: bone marrow transplantation for severe thalassaemia (1). The view from Pesaro (2). To be or not to be. Br J Haematol. 1991;78(3):300-303.
11. Lucarelli G, Galimberti M, Polchi P, et al. Bonemarrow transplantation in adult thalassemia. Blood. 1992;80(6):1603-1607.
12. Lucarelli G, Galimberti M, Polchi P, et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med. 1993;329(12):840-844.
13. Lucarelli G, Andreani M, Angelucci E. The cure of thalassemia by bone marrow transplantation. Blood Rev. 2002;16(2):81-85.
14. Giardini C, Lucarelli G. Bone marrow transplantation for betathalassemia. Hematol Oncol Clin North Am. 1999;13(5):1059-1064, viii.
15. Gratwohl A, Baldomero H, Schwendener A, et al. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant. 2009;43(4):275-291.
16. Frassoni F, Labopin M, Powles, et al. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Effect of center on outcome of bone marrow transplantation for acute myeloid leukemia. Lancet. 2005;355:1393-1398
17. Gratwohl A, Baldomero H, Horisberger B, et al. Current trends in hematopoietic stem cell transplantation in Europe. Blood. 2002;100(7):2374-2386.
18. Gratwohl A, Baldomero H, Passweg J, et al. Hematopoietic stem cell transplantation for hematological malignancies in Europe. Leukemia. 2003;17(5):941-959.
19. Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A; Joint Accreditation Committee, International Society for Cellular Therapy; European Group for Blood and Marrow Transplantation. EBMT activity survey 2004 and changes in disease indication over the past 15 years. Bone Marrow Transplant. 2006;37(12):1069-1085.
20. Bacigalupo A, Brand R, Oneto R, et al. Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy - The European Group for Blood and Marrow Transplantation experience. Semin Hematol. 2000;37(1):69-80.
21. Bacigalupo A. Treatment strategies for patients with severe aplastic anemia. Bone Marrow Transplant. 2008;42(suppl 1):S42-S44.
22. Gratwohl A, Baldomero H, Schwendener A, et al. Predictability of hematopoietic stem cell transplantation rates. Haematologica. 2007;92(12):1679-1686.